Superiority complex? It is complex

Associate Professor Susan Carden examines the RAINBOW study, which compared treatment of ROP with ranibizumab versus laser therapy. Noting the extension trial may uncover more, there might be a superior treatment method. Listen in to find out more.

View article here 

Susan Carden is an Associate Professor in the Department of Pediatrics, University of Melbourne.  She is a Consultant Ophthalmologist R...

For Fuchs’s sake, taking out the sting

Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs’ Endothelial Dystrophy

Professor Stephanie Watson talks taking the sting out of Hyperosmolar Eye Drops for Diurnal Corneal Edema in Fuchs’ Endothelial Dystrophy. Do the clinical outcomes support their use, and how robust was this Double-Masked, Randomized Controlled Trial?

View article here

Stephanie Watson is the Head of the Corneal Resear...

Talking “pulleyes”… and when they no longer hold tension 

When a trans-pacific collaboration results in need-to-know outcomes for the general ophthalmologist. The differences in patterns of sagging eye syndrome lead to different treatment paths. Dr Sonia Moorthy unpacks diagnosis, simple and effective management strategies and ways to reduce unnecessary investigations. 

View article here

Sonia Moorthy is an adult and paediatric ophtha...

Rebounds are not limited to basketball.  Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout. 

Rebounds are not limited to basketball. Dr Sarah Hull examines the rebound effect in the Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study. What are the outcomes of continued atropine treatment, and what is the ideal concentration? 

V...

Beyond the surface. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

A modern landmark glaucoma trial and first-of-its-kind that provides surprising and useful outcomes for current practice and research. Can the visual field be preserved with an intraocular-pressure-lowering drug in patients with open-angle glaucoma? Dr Jennifer Fan Gaskin explores Latanoprost for open-angle glaucoma.

V...

Considering it all. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3- year follow-up study

Dr Caroline Catt investigates myopia progression and axial elongation in children. Limitations on data impact treatment choices – what should be considered for DIMs lenses? Age, ethnicity, cost, access? Caroline considers it all, providing practical advice for anyone seei...

Mucking out the stables. The Ruptured Globe, Sympathetic Ophthalmia, and the 14-Day Rule

Dr Freny Kalapesi examines the basis of the 14-day rule in treating ruptured globes to prevent sympathetic ophthalmia. A key takeaway is understanding the importance of whole-of-person care when considering treatment options.

View article here

Freny Kalapesi is an Oculoplastic Surgeon who works at Westmead public hospital and the Chris O'Brie...

Can weight loss cure eye disease?

Effectiveness of Bariatric Surgery vs Community Weight Management Intervention for the Treatment of Idiopathic Intracranial Hypertension.

Can weight loss cure eye disease? In the case of Idiopathic Intracranial Hypertension (IIH), yes! A/Prof Clare Fraser talks us through the much-awaited follow-up article examining the Effectiveness of Bariatric Surgery vs Community Weight Management Intervention fo...

Eplerenone for Chronic Central Serous Chorioretinopathy in Patients with Active, Previously Untreated Disease for more than 4 Months (VICI): A Randomised, Double-blind, Placebo-controlled Trial

The VICI trial is highly topical. Dr Narme Deva, Consultant Ophthalmologist & Honorary Senior Lecturer at the University of Auckland, explores the Eplerenone for chronic central serous chorioretinopathy in patients with active, p...

Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy (Protocol AB) 
Dr Cheryl Au, current medical retinal fellow at Westmead Hospital, explores Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage from Proliferative Diabetic Retinopathy. She was prompted to review the article due to frequent presentation of patients presenting with vitreous haemorrhage f...

Is Rituximab a Wonder-drug?
 
Dr Diana Conrad, Director of the Uveitis Service at the Royal Women’s and Children’s Hospital (the only speciality uveitis service in Queensland) explores a review paper on the use of rituximab for the treatment of non-infectious uveitis and scleritis. Dr Conrad notes an impressive response rate to rituximab for patients where first and second-line treatments have failed. Given the success of r...

Selective Laser Trabeculoplasty: A Review Published in RANZCO’s own Clinical and Experimental Ophthalmology
Selective laser trabeculoplasty (SLT) has become an essential part of glaucoma management. In this 10 Minutes of Science, Dr Alina Zeldovich explores Selective laser trabeculoplasty: A review published in RANZCO’s own Clinical and Experimental Ophthalmology. Alina is a cataract surgeon who has been using SLT more frequent...

Clinical Results of Topography-based Customized Ablations in Highly Aberrated Eyes and Keratoconus/Ectasia with Cross-linking

On the laser’s edge – breaking taboos! Dr Aanchal Gupta is the Director of Training for the South Australian Training network and a Senior Clinical lecturer at the University of Adelaide. She reviews Clinical results of topography-based customized ablations in highly aberrated eyes and keratoconus/ec...

Laser-assisted in Situ Keratomileusis Long Term Outcomes in Late Adolescence
Challenging the norms and parameters of safe LASIK surgery in late adolescents with Dr Tanya Trinh, cornea and refractive surgeon and staff specialist at Sydney Eye Hospital. Myopic disease burden is significant, increasing and contributes to serious comorbidities with progression over time. Laser-assisted in situ keratomileusis long term outcomes in l...

Periocular Triamcinolone versus Intravitreal Triamcinolone versus Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular versus INTravitreal Corticosteroids for Uveitic Macular Edema (POINT) Trial

Dr Priya Samalia is a medical retina and uveitis fellow working at the Royal Victorian Eye and Ear Hospital. She examines the POINT trail on effectiveness of Periocular Triamcinolone vs. Intr...

Accuracy of Intraocular Lens Power Formulas Modified for Patients with Keratoconus

Which IOL formula should we use prior to cataract surgery in patients with keratoconus?  Are the newer formulae with keratoconus modifications more accurate than the regular formulae that we are used to using?  What should be our refractive target for these cases and how does it vary according to severity of the cone?  Can we aim for spectacl...

Associations Between Anterior Segment Parameters and Rotational Stability of a Plate-haptic Toric Intraocular Lens

At face value – does the data always support the conclusion? Dr Madeleine Adams,  a cataract surgeon and comprehensive ophthalmologist with a PhD from the University of Melbourne for her research into age-related macular degeneration, offers a cautionary message about always critically scrutinising data present...

Factors Affecting Corneal Incision Position During Femtosecond Laser-assisted Cataract Surgery
Dr Kerrie Meades was the first female ophthalmologist to perform laser vision correct in Australia. In this podcast, Dr Meades discusses the article Factors affecting corneal incision position during femtosecond laser-assisted cataract surgery. Dr Meades was prompted to explore this topic due to a lack of precision from laser for the...

The Pneumatic Retinopexy versus Vitrectomy for the Management of Primary Rhegmatogenous Retinal Detachment Outcomes Randomized Trial (PIVOT)

Dr Mali Okada is a consultant at the RVEEH and senior researcher at CERA. In this podcast she discusses the various management options of retinal detachment. Pneumatic retinopexy is routinely used as the first line treatment in many parts of the world for superior retinal detachments, ...